Life360 (LIFX) Cash & Equivalents (2020 - 2026)

Life360 (LIFX) has 7 years of Cash & Equivalents data on file, last reported at $239.4 million in Q1 2026.

• Cash & Equivalents for Q1 2026 came in at $239.4 million, up 41.76% year-over-year; the trailing twelve-month figure through Mar 2026 was $239.4 million (up 41.76% YoY), and the FY2025 annual result was $332.8 million, up 109.0% from the prior year.
• Cash & Equivalents declined to $239.4 million in Q1 2026 per LIFX's latest filing, from $332.8 million in the prior quarter.
• Over five years, Cash & Equivalents peaked at $455.7 million in Q3 2025 and troughed at $44.0 million in Q3 2022.
• A 5-year average of $159.0 million and a median of $82.7 million in 2022 frame the typical range for Cash & Equivalents.
• The sharpest annual moves came in 2022 and 2025: Cash & Equivalents plunged 67.34% in 2022, then jumped 186.66% in 2025.
• A 5-year view of Cash & Equivalents shows it stood at $75.4 million in 2022, then decreased by 8.59% to $69.0 million in 2023, then soared by 130.9% to $159.2 million in 2024, then surged by 109.0% to $332.8 million in 2025, then retreated by 28.08% to $239.4 million in 2026.
• Business Quant data shows LIFX's Cash & Equivalents at $239.4 million in Q1 2026, $332.8 million in Q4 2025, and $455.7 million in Q3 2025.